DashboardPortfoliosWatchlistCommunityDiscoverScreener
NOT FOR DISTRIBUTION
Loading...
  • Stocks
  • /
  • Materials
Updated 6h ago
GIVN logo

Givaudan SASWX:GIVN Stock Report

Market Cap CHF 29.2b
Updated 6h ago
Share Price
n/a
1Y-7.2%
7D-2.6%
1D0.2%
Portfolio Value
​
View

Givaudan SA

SWX:GIVN Stock Report

Market Cap: CHF 29.2b

  • Company Overview
  • Valuation
  • Future Growth
  • Past Performance
  • Financial Health
  • Dividend
  • Management
  • Ownership
  • Other Information
  • Stock Community

Givaudan (GIVN) Stock Overview

Engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. More details

GIVN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance2/6
Financial Health5/6
Dividends5/6

Rewards

Trading at 26.8% below our estimate of its fair value

Earnings are forecast to grow 9.12% per year

Pays a reliable dividend of 2.28%

Risk Analysis

Has a high level of debt


GIVN Community Fair Values

Create Narrative

See what 34 others think this stock is worth. Follow their fair value or set your own to get alerts.

Analyst Price Targets

AN
AnalystConsensusTarget
8.8% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts

251
0
20
AN
AnalystLowTarget
9.6% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Rising Regulatory Scrutiny And Raw Material Costs Will Undermine Prospects

60
0
1
AN
AnalystHighTarget
21.1% undervalued intrinsic discount
AnalystHighTarget
•2d ago

Rising Middle Class In Asia Will Drive Clean Premium Demand

19
0
0

Top Analyst Narratives

AN
AnalystConsensusTarget
8.8% undervalued intrinsic discount
AnalystConsensusTarget
•2mo ago

Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts

251
0
20
AN
AnalystLowTarget
9.6% overvalued intrinsic discount
AnalystLowTarget
•1mo ago

Rising Regulatory Scrutiny And Raw Material Costs Will Undermine Prospects

60
0
1
AN
AnalystHighTarget
21.1% undervalued intrinsic discount
AnalystHighTarget
•2d ago

Rising Middle Class In Asia Will Drive Clean Premium Demand

19
0
0
View all narratives

Givaudan SA Competitors

Sika

Symbol: SWX:SIKA
Market cap: CHF 29.7b

EMS-CHEMIE HOLDING

Symbol: SWX:EMSN
Market cap: CHF 18.6b

Amrize

Symbol: SWX:AMRZ
Market cap: CHF 18.1b

Gurit Holding

Symbol: SWX:GURN
Market cap: CHF 268.1m

Price History & Performance

Summary of share price highs, lows and changes for Givaudan
Historical stock prices
Current Share PriceCHF 3,164.00
52 Week HighCHF 3,592.00
52 Week LowCHF 2,566.00
Beta0.66
1 Month Change-3.54%
3 Month Change-0.57%
1 Year Change-7.24%
3 Year Change10.28%
5 Year Change-29.52%
Change since IPO520.39%

Recent News & Updates

User avatar
Narrative Update • Sep 09

GIVN: Broader Execution And Lower Oil Costs Will Support Future Re Rating

Givaudan's analyst-derived fair value estimate has been trimmed from CHF 4,283.53 to CHF 4,010.60 as analysts balance a wider range of price targets, with some citing pressure on Fine Fragrance premiumization and mixed ratings across the stock. Analyst Commentary Recent research on Givaudan shows a split set of views, but there are several points that more optimistic analysts continue to highlight.
User avatar
Narrative Update • Jul 27

GIVN: Premium Will Face Pressure If Sector Rotation Extends

The new analyst price target for Givaudan is set at CHF 2,886, up from CHF 2,800. It reflects updated assumptions on fair value, discount rate and long term growth, and sits within a wide CHF 2,886 to CHF 3,650 range of recent Street targets and mixed ratings from Underperform to Buy.
Analysis Article • Jul 26

Analysts Are Updating Their Givaudan SA (VTX:GIVN) Estimates After Its Half-Yearly Results

Givaudan SA ( VTX:GIVN ) shareholders are probably feeling a little disappointed, since its shares fell 6.6% to...
User avatar
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.

Recent updates

User avatar
Narrative Update • Sep 09

GIVN: Broader Execution And Lower Oil Costs Will Support Future Re Rating

Givaudan's analyst-derived fair value estimate has been trimmed from CHF 4,283.53 to CHF 4,010.60 as analysts balance a wider range of price targets, with some citing pressure on Fine Fragrance premiumization and mixed ratings across the stock. Analyst Commentary Recent research on Givaudan shows a split set of views, but there are several points that more optimistic analysts continue to highlight.
User avatar
Narrative Update • Jul 27

GIVN: Premium Will Face Pressure If Sector Rotation Extends

The new analyst price target for Givaudan is set at CHF 2,886, up from CHF 2,800. It reflects updated assumptions on fair value, discount rate and long term growth, and sits within a wide CHF 2,886 to CHF 3,650 range of recent Street targets and mixed ratings from Underperform to Buy.
Analysis Article • Jul 26

Analysts Are Updating Their Givaudan SA (VTX:GIVN) Estimates After Its Half-Yearly Results

Givaudan SA ( VTX:GIVN ) shareholders are probably feeling a little disappointed, since its shares fell 6.6% to...
User avatar
Narrative Update • Jun 25

GIVN: Pricing Power And AI Beauty Push Will Shape Future Margin Resilience

Givaudan's analyst fair value estimate has been adjusted modestly higher to CHF 3,468 from CHF 3,415, reflecting analysts' updated assumptions for slightly stronger revenue growth, a similar discount rate, a broadly unchanged profit margin profile, and a small increase in expected future P/E multiples, alongside a recent series of price target revisions across the Street that now cluster in the CHF 2,900 to CHF 3,500 range. Analyst Commentary Recent research on Givaudan points to a mixed but generally constructive view, with several firms adjusting price targets in a relatively tight CHF 2,900 to CHF 3,500 band and a blend of rating upgrades and downgrades.
User avatar
Narrative Update • Jun 09

GIVN: Pricing Power And Eurofragance Deal Will Support Future Margin Resilience

The analyst price target for Givaudan has been adjusted slightly to CHF 3,415 from CHF 3,447. This reflects a blend of cautious tweaks to growth and discount rate assumptions.
User avatar
Narrative Update • May 26

GIVN: AI Beauty Partnership Will Support Future Re Rating Potential

Analysts have trimmed their Givaudan fair value estimate from CHF 5,040 to about CHF 4,284, reflecting expectations of lower revenue growth, slightly softer profit margins, a modestly reduced discount rate, and a lower future P/E multiple following a series of recent target cuts and rating changes. Analyst Commentary Recent Street research on Givaudan has been mixed, with several cuts to price targets and rating changes, but not all commentary has been negative.
User avatar
Narrative Update • May 02

GIVN: Fair Outlook Will Reflect Split Bank Views And AI Beauty Push

Givaudan's analyst price target has been reset from CHF 2,875 to CHF 2,800, as analysts weigh recent upgrades alongside a mix of smaller target increases and larger reductions from major banks. Analyst Commentary Recent Street research around Givaudan has been mixed, with some upgrades and modest price target increases sitting alongside a series of larger cuts and downgrades from major banks.
User avatar
Narrative Update • Apr 18

GIVN: Fair Outlook Balances Dividend Stability With Mixed Bank Rating Revisions

Givaudan's analyst price target is held at CHF 2,875, with minor adjustments to the discount rate, revenue growth, and profit margin assumptions reflecting a mixed set of recent analyst actions, including modest price target changes and rating shifts across major banks. Analyst Commentary Recent research on Givaudan shows a split view, with some large banks turning more constructive while several bearish analysts continue to flag risks around valuation and execution.
User avatar
Narrative Update • Apr 04

GIVN: Cautious Downgrades Will Support Future Margin Resilience And Re Rating Potential

Givaudan's analyst price target has been reduced from about CHF 3,748 to roughly CHF 3,447. This reflects analysts' recent rounds of target cuts and downgrades following more cautious assumptions on growth, margins and future P/E multiples.
User avatar
Narrative Update • Mar 21

GIVN: Fair Stance Will Balance Dividend Appeal And Cautious Bank Revisions

Givaudan's analyst price target is trimmed to CHF 2,875 from CHF 2,900 as analysts factor in more cautious assumptions about revenue growth, slightly firmer profit margins and updated P/E expectations following a series of recent target cuts across the Street. Analyst Commentary Recent Street research around Givaudan has leaned more cautious, with several bearish analysts trimming price targets and reassessing the risk and reward trade off.
User avatar
Narrative Update • Mar 06

GIVN: Fair Stance Will Weigh Dividend Support Against Cautious Bank Views

Analysts have trimmed their Givaudan price targets by up to several hundred CHF, reflecting slightly lower assumptions for revenue growth and profit margins while keeping fair value broadly anchored around CHF 2,900 as they adjust discount rate and P/E inputs. Analyst Commentary Recent Street research on Givaudan skews cautious, with several bearish analysts cutting price targets by CHF 150 to CHF 400 as they reset their expectations around revenue growth, margins, and the appropriate P/E to pay for the shares.
User avatar
Narrative Update • Feb 20

GIVN: Fair Stance Will Reflect Cautious Bank Views On Future Earnings

Analysts have lowered their price target on Givaudan to CHF 2,900 from CHF 3,100, reflecting updated assumptions around slightly higher discount rates, more cautious revenue growth, a marginally lower profit margin outlook, and a modestly reduced future P/E multiple in light of recent target cuts and a downgrade from several major banks. Analyst Commentary Recent Street research on Givaudan has tilted more cautious, with a cluster of price target cuts and at least one fresh downgrade from a major global bank.
User avatar
Narrative Update • Feb 06

GIVN: Chinese Pricing Pressure Will Support Future Margin Resilience And Re Rating Potential

Analysts have reduced their fair value estimate for Givaudan from CHF 3,946.93 to CHF 3,747.83. This change reflects a series of lower Street price targets and incorporates assumptions for steady revenue growth, slightly higher profit margins and a lower future P/E multiple.
Analysis Article • Feb 01

Givaudan (VTX:GIVN) Is Increasing Its Dividend To CHF72.00

The board of Givaudan SA ( VTX:GIVN ) has announced that it will be paying its dividend of CHF72.00 on the 25th of...
User avatar
Narrative Update • Jan 23

GIVN: Recalibrated Valuation Support Will Sustain Outperformance Versus Chinese Pricing Pressure

Our updated analyst price target for Givaudan shifts to CHF 3,947 from CHF 4,021, as analysts factor in only modest adjustments to growth, margins, and future P/E assumptions, while recent upgrades highlight improved relative positioning and valuation support. Analyst Commentary Recent research suggests sentiment around Givaudan is improving, with upgrades linked mainly to valuation support and relative positioning versus peers, rather than big changes to fundamental assumptions.
User avatar
Narrative Update • Jan 09

GIVN: Fair Stance Will Reflect Resilience To Chinese Pricing Pressure

Analysts now frame their Givaudan price target at CHF 3,100, with updated assumptions reflecting a 3.9% revenue growth outlook, a 15.4% profit margin profile, and a forward P/E of about 24.5x. This view is supported by recent upgrades that highlight valuation and relative resilience versus Chinese competition and pricing pressure.
User avatar
Narrative Update • Dec 18

GIVN Will Face Mixed Rating Shifts Amid Intensifying Competition And Pricing Pressures

Analysts have trimmed their price target for Givaudan by CHF 100 to CHF 3,100. This reflects slightly softer assumptions for long term revenue growth and margins, even as they continue to view the company as relatively well positioned against intensifying competition and pricing pressures.
User avatar
Narrative Update • Dec 04

GIVN: Peer-Leading Organic Sales Will Sustain Outperformance Versus Chinese Competition

Analysts have nudged their fair value estimate for Givaudan slightly higher, from approximately CHF 3,995 to CHF 4,021. This reflects modest upgrades to long term revenue growth and profit margin assumptions as they emphasize the company’s relative resilience to Chinese competition and its peer leading organic sales growth.
Analysis Article • Nov 28

Subdued Growth No Barrier To Givaudan SA's (VTX:GIVN) Price

When close to half the companies in Switzerland have price-to-earnings ratios (or "P/E's") below 19x, you may consider...
User avatar
Narrative Update • Nov 20

GIVN: Peer-Leading Organic Sales Growth Will Drive Outperformance Amid Competitive Pressures

Analysts have slightly reduced their fair value estimate for Givaudan, lowering the price target from approximately CHF 4,005 to CHF 3,995. This adjustment reflects recent cautious sentiment amid ongoing pricing and competitive pressures in the sector.
Analysis Article • Nov 12

Returns At Givaudan (VTX:GIVN) Are On The Way Up

To find a multi-bagger stock, what are the underlying trends we should look for in a business? Ideally, a business will...
User avatar
Narrative Update • Nov 05

GIVN: Peer-Leading Organic Sales Growth Will Support Share Price Recovery

Analysts have decreased their price targets for Givaudan, citing persistent challenges in the consumer chemicals sector and a cautious outlook on peer-relative performance. The targets now range from CHF 3,300 to CHF 3,725, down from previous estimates by several hundred francs.
Analysis Article • Oct 28

Estimating The Intrinsic Value Of Givaudan SA (VTX:GIVN)

Key Insights Using the 2 Stage Free Cash Flow to Equity, Givaudan fair value estimate is CHF4,284 With CHF3,471 share...
User avatar
Narrative Update • Oct 22

Analysts Weigh Givaudan’s Outlook Amid CEO Transition and Adjusted Growth Forecasts

Analysts have slightly raised Givaudan's fair value estimate from CHF 3,996.53 to CHF 4,005.42. This change reflects updated expectations in light of moderated growth forecasts and cautious sentiment highlighted in recent price target revisions.
User avatar
Narrative Update • Oct 08

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Givaudan's analyst price target has been revised downward from CHF 4,081.95 to CHF 3,996.53, reflecting slightly lower revenue growth expectations and profit margin forecasts according to recent analyst updates. Analyst Commentary Recent analyst activity on Givaudan has resulted in a mix of revised targets and sentiment shifts that reflect both optimism around the company's strengths and caution regarding its outlook in the current market environment.
User avatar
Narrative Update • Sep 23

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Despite near-term pressures and a sector-wide derating, analysts remain positive on Givaudan's strong organic sales growth and long-term structural opportunities—particularly from regulatory-driven reformulation trends—resulting in only a marginal reduction of the consensus price target from CHF4127 to CHF4082. Analyst Commentary Givaudan is recognized for peer-leading organic sales growth, positioning it as a best-in-class flavor and fragrance company.
Analysis Article • Sep 22

Here's Why We Think Givaudan (VTX:GIVN) Is Well Worth Watching

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...
User avatar
Narrative Update • Sep 04

Emerging Markets And Sustainable Ingredients Will Drive Future Expansion

Analysts remain moderately optimistic on Givaudan, citing long-term benefits from regulatory-driven reformulation and market share gains tempered by near-term margin pressures and valuation concerns, resulting in an unchanged consensus price target of CHF4127. Analyst Commentary Bullish analysts expect Givaudan to benefit from industry-wide reformulation trends starting in 2026 as regulatory pressures phase out synthetic colors and ingredients, particularly in the U.S. Increases in price targets reflect confidence in Givaudan’s ability to capture incremental market share and drive organic growth amid evolving consumer preferences.
User avatar
New Narrative • Jan 26

Bloomful Splash Launch Will Drive Future Success In Fragrance & Beauty

Strategic leadership changes and portfolio expansions may drive growth in revenue and earnings.

Shareholder Returns

GIVNCH ChemicalsCH Market
7D-2.6%-2.0%-3.8%
1Y-7.2%3.9%10.2%

Return vs Industry: GIVN underperformed the Swiss Chemicals industry which returned 3.9% over the past year.

Return vs Market: GIVN underperformed the Swiss Market which returned 10.2% over the past year.

Price Volatility

Is GIVN's price volatile compared to industry and market?
GIVN volatility
GIVN Average Weekly Movement3.5%
Chemicals Industry Average Movement4.8%
Market Average Movement4.0%
10% most volatile stocks in CH Market7.5%
10% least volatile stocks in CH Market2.0%

Stable Share Price: GIVN has not had significant price volatility in the past 3 months compared to the Swiss market.

Volatility Over Time: GIVN's weekly volatility (3%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
179617,508Christian Stammkoetterwww.givaudan.com

Givaudan SA engages in the manufacture, supply, and sale of fragrance, beauty, taste, and wellbeing products to the consumer goods industry. It operates in two divisions, Fragrance & Beauty, and Taste & Wellbeing. The Fragrance & Beauty division offers fine fragrances; consumer products, such as personal, home, fabric, and oral care; fragrance ingredients; and active beauty products.

Givaudan SA Fundamentals Summary

How do Givaudan's earnings and revenue compare to its market cap?
GIVN fundamental statistics
Market capCHF 29.21b
Earnings (TTM)CHF 954.00m
Revenue (TTM)CHF 7.41b
30.6x
P/E Ratio
3.9x
P/S Ratio

Is GIVN overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GIVN income statement (TTM)
RevenueCHF 7.41b
Cost of RevenueCHF 4.17b
Gross ProfitCHF 3.24b
Other ExpensesCHF 2.29b
EarningsCHF 954.00m

Last Reported Earnings

Jun 30, 2026

Next Earnings Date

Jan 27, 2027

Earnings per share (EPS)103.34
Gross Margin43.73%
Net Profit Margin12.88%
Debt/Equity Ratio102.0%

How did GIVN perform over the long term?

See historical performance and comparison

Dividends

2.3%
Current Dividend Yield
70%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/11 23:25
End of Day Share Price 2026/09/11 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
  • SEC Form 10-K
  • SEC Form 10-Q
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
  • Analyst Research Reports
  • Blue Matrix
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
  • ICE Market Data
  • SEC Form S-1
Ownership10 years
  • Top shareholders
  • Insider trading
  • SEC Form 4
  • SEC Form 13D
Management10 years
  • Leadership team
  • Board of directors
  • SEC Form 10-K
  • SEC Form DEF 14A
Key Developments10 years
  • Company announcements
  • SEC Form 8-K

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Givaudan SA is covered by 39 analysts. 18 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Konstantin WiechertBaader Helvea Equity Research
Volker BosseBaader Helvea Equity Research
Robert BateBarclays

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide